Athanor Capital, LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
Athanor Capital, LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$400,000
-56.0%
18,885
-69.2%
0.01%
-74.3%
Q3 2020$909,000
+154.6%
61,320
+152.9%
0.04%
+94.4%
Q2 2020$357,000
-63.0%
24,242
-30.7%
0.02%
-96.0%
Q1 2018$966,00035,0000.45%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders